Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

Alterations in Muscle Tone ll

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Device aided therapies in Parkinson disease: an expert view on apomorphine.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026

Same authorSame journal

Divergent presentations of anti-GAD autoimmunity: a comparative analysis of two neurodegenerative cases.

Parkinsonism & related disorders·2026

Same author

Associations of IL-17 and TGF-β1 with physical frailty in older adults.

GeroScience·2026

Same author

Distinct neurostructural, cognitive, and neuropsychiatric associations of plasma p-tau217, and Aβ42/40 in Parkinson's disease and aging cohorts.

Frontiers in aging neuroscience·2026

Same author

Associations of daily step counts with cognitive, clinical, and resting-state electroencephalographic measures in patients with cognitive decline due to Alzheimer's disease.

GeroScience·2026

Same author

Overcoming the diagnostic gap in mild cognitive impairment in Parkinson's disease: a pilot study employing a machine learning-/augmented reality-based digital biomarker.

Frontiers in aging neuroscience·2026

Search research articles

Related Experiment Video

Updated: May 31, 2026

Measuring Constipation in a Drosophila Model of Parkinson's Disease

Measuring Constipation in a Drosophila Model of Parkinson's Disease

Published on: September 22, 2023

Parkinson's disease: the non-motor issues.

K Ray Chaudhuri¹, Per Odin, Angelo Antonini

¹National Parkinson Foundation Centre of Excellence, King's College Hospital, Kings College, Denmark Hill, London, UK. ray.chaudhuri@nhs.net

Parkinsonism & Related Disorders

|July 12, 2011

Summary

The total burden of non-motor symptoms (NMS) significantly impacts Parkinson's disease quality of life. Recent advancements include validated tools and clinical trials focusing on NMS assessment and management.

Related Experiment Videos

Last Updated: May 31, 2026

Measuring Constipation in a Drosophila Model of Parkinson's Disease

Measuring Constipation in a Drosophila Model of Parkinson's Disease

Published on: September 22, 2023

Area of Science:

Neurology
Gerontology
Clinical Medicine

Background:

Non-motor symptoms (NMS) in Parkinson's disease (PD) are often overlooked, despite their significant impact on patient quality of life.
Emerging evidence suggests the cumulative burden of NMS, rather than individual symptoms, is the primary determinant of quality of life in PD.

Purpose of the Study:

To review current understanding and management strategies for non-motor symptoms in Parkinson's disease.
To highlight recent advancements in the assessment and clinical trial incorporation of NMS in PD.

Main Methods:

Review of recent literature on NMS in Parkinson's disease.
Discussion of newly validated assessment tools for NMS.
Analysis of the role of NMS in clinical trials and treatment recommendations.

Main Results:

The overall burden of NMS is a critical factor affecting quality of life in Parkinson's disease.
Validated tools like NMSQuest, NMS scale, SCOPA scales, and modified MDS-UPDRS are now available for clinical assessment.
Non-motor measures are increasingly included as outcomes in clinical trials for PD.

Conclusions:

There is a growing recognition of the importance of non-motor symptoms in Parkinson's disease management.
The development and validation of assessment tools are improving the clinical evaluation of NMS.
Future research and clinical practice are increasingly integrating NMS into the holistic management of Parkinson's disease.